Publication | Open Access

A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction

Pancreatic CancerGastrointestinal OncologyMedicineGastroenterologyPathologyEsophagogastric JunctionCancer TreatmentOncologyRadiation OncologyCancer ResearchMetastatic Adenocarcinoma